Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis.
Journal: Expert review of clinical pharmacology
Published: March 05, 2024
Efficacy of vedolizumab during intravenous induction therapy in ulcerative colitis and Crohn's disease: post hoc analysis of patient-reported outcomes from the VISIBLE 1 and 2 studies.
Journal: European journal of gastroenterology & hepatology
Published: February 28, 2024
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies.
Journal: Crohn's & colitis 360
Published: January 12, 2023
Response to letter to editor.
Journal: Journal of biopharmaceutical statistics
Published: May 23, 2022
Using supervised machine learning approach to predict treatment outcomes of vedolizumab in ulcerative colitis patients.
Journal: Journal of biopharmaceutical statistics
Published: December 09, 2021
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
Journal: Journal of Crohn's & colitis
Published: August 17, 2021
A hybrid approach of handling missing data under different missing data mechanisms: VISIBLE 1 and VARSITY trials for ulcerative colitis.
Journal: Contemporary clinical trials
Published: August 25, 2020
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 01, 2017
Metformin inhibits the growth of human pancreatic cancer xenografts.
Journal: Pancreas
Published: March 07, 2013
Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK.
Journal: Biochemical and biophysical research communications
Published: October 29, 2012
Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
Journal: PloS one
Published: August 28, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026